1. Home
  2. HCWB vs JL Comparison

HCWB vs JL Comparison

Compare HCWB & JL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCWB
  • JL
  • Stock Information
  • Founded
  • HCWB 2018
  • JL 1985
  • Country
  • HCWB United States
  • JL Hong Kong
  • Employees
  • HCWB N/A
  • JL N/A
  • Industry
  • HCWB Biotechnology: Pharmaceutical Preparations
  • JL
  • Sector
  • HCWB Health Care
  • JL
  • Exchange
  • HCWB Nasdaq
  • JL NYSE
  • Market Cap
  • HCWB 17.2M
  • JL 14.6M
  • IPO Year
  • HCWB 2021
  • JL 2024
  • Fundamental
  • Price
  • HCWB $0.39
  • JL $4.91
  • Analyst Decision
  • HCWB
  • JL
  • Analyst Count
  • HCWB 0
  • JL 0
  • Target Price
  • HCWB N/A
  • JL N/A
  • AVG Volume (30 Days)
  • HCWB 18.3M
  • JL 336.7K
  • Earning Date
  • HCWB 03-31-2025
  • JL 03-25-2025
  • Dividend Yield
  • HCWB N/A
  • JL 3.87%
  • EPS Growth
  • HCWB N/A
  • JL N/A
  • EPS
  • HCWB N/A
  • JL 0.54
  • Revenue
  • HCWB $3,495,990.00
  • JL $32,831,195.00
  • Revenue This Year
  • HCWB $229.19
  • JL N/A
  • Revenue Next Year
  • HCWB N/A
  • JL N/A
  • P/E Ratio
  • HCWB N/A
  • JL $9.09
  • Revenue Growth
  • HCWB 22.27
  • JL N/A
  • 52 Week Low
  • HCWB $0.21
  • JL $0.23
  • 52 Week High
  • HCWB $2.52
  • JL $29.95
  • Technical
  • Relative Strength Index (RSI)
  • HCWB 48.72
  • JL 52.26
  • Support Level
  • HCWB $0.38
  • JL $3.28
  • Resistance Level
  • HCWB $0.42
  • JL $6.50
  • Average True Range (ATR)
  • HCWB 0.09
  • JL 0.76
  • MACD
  • HCWB -0.00
  • JL 0.03
  • Stochastic Oscillator
  • HCWB 4.48
  • JL 50.62

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About JL J-LONG GROUP LIMITED

J-Long Group Ltd is an established distributor in Hong Kong of reflective and non-reflective garment trims including, among others, heat transfers, fabrics, woven labels and tapes, sewing badges, piping, zipper pullers and drawcords. It also offers a wide range of apparel solution services to cater to its customers' needs for reflective and non-reflective garment trims, ranging from market trend analysis, product design and development and production to quality control.

Share on Social Networks: